vs
Side-by-side financial comparison of Sight Sciences, Inc. (SGHT) and Zeo Energy Corp. (ZEO). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $18.6M, roughly 1.1× Zeo Energy Corp.). Zeo Energy Corp. runs the higher net margin — -10.8% vs -20.4%, a 9.6% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -0.4%). Zeo Energy Corp. produced more free cash flow last quarter ($2.3M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs -4.0%).
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
SGHT vs ZEO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.4M | $18.6M |
| Net Profit | $-4.2M | $-2.0M |
| Gross Margin | 87.3% | — |
| Operating Margin | -18.0% | -11.8% |
| Net Margin | -20.4% | -10.8% |
| Revenue YoY | 6.9% | -0.4% |
| Net Profit YoY | 64.9% | -360.9% |
| EPS (diluted) | $-0.07 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.4M | $18.6M | ||
| Q3 25 | $19.9M | $23.9M | ||
| Q2 25 | $19.6M | $18.1M | ||
| Q1 25 | $17.5M | $8.8M | ||
| Q4 24 | $19.1M | $18.6M | ||
| Q3 24 | $20.2M | $19.7M | ||
| Q2 24 | $21.4M | $14.8M | ||
| Q1 24 | $19.3M | $20.1M |
| Q4 25 | $-4.2M | $-2.0M | ||
| Q3 25 | $-8.2M | $-3.2M | ||
| Q2 25 | $-11.9M | $-2.4M | ||
| Q1 25 | $-14.2M | $-6.4M | ||
| Q4 24 | $-11.8M | $-435.3K | ||
| Q3 24 | $-11.1M | $-424.3K | ||
| Q2 24 | $-12.3M | $-277.8K | ||
| Q1 24 | $-16.3M | $-1.5M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 86.4% | 57.9% | ||
| Q2 25 | 84.8% | 59.8% | ||
| Q1 25 | 86.2% | 99.3% | ||
| Q4 24 | 86.8% | — | ||
| Q3 24 | 83.9% | 50.2% | ||
| Q2 24 | 85.8% | 52.3% | ||
| Q1 24 | 85.5% | — |
| Q4 25 | -18.0% | -11.8% | ||
| Q3 25 | -39.7% | -8.3% | ||
| Q2 25 | -59.6% | -15.8% | ||
| Q1 25 | -79.2% | -153.8% | ||
| Q4 24 | -62.5% | -6.0% | ||
| Q3 24 | -55.7% | -15.2% | ||
| Q2 24 | -59.2% | -18.0% | ||
| Q1 24 | -76.4% | -20.1% |
| Q4 25 | -20.4% | -10.8% | ||
| Q3 25 | -41.0% | -13.5% | ||
| Q2 25 | -61.0% | -13.3% | ||
| Q1 25 | -80.8% | -72.4% | ||
| Q4 24 | -62.1% | -2.3% | ||
| Q3 24 | -54.9% | -2.2% | ||
| Q2 24 | -57.7% | -1.9% | ||
| Q1 24 | -84.4% | -7.6% |
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.23 | — | ||
| Q1 25 | $-0.28 | $-0.48 | ||
| Q4 24 | $-0.23 | $1.11 | ||
| Q3 24 | $-0.22 | $-0.08 | ||
| Q2 24 | $-0.25 | $0.03 | ||
| Q1 24 | $-0.33 | $-1.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $92.0M | $6.1M |
| Total DebtLower is stronger | $42.4M | $79.1K |
| Stockholders' EquityBook value | $63.9M | $5.3M |
| Total Assets | $115.3M | $56.9M |
| Debt / EquityLower = less leverage | 0.66× | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $92.0M | $6.1M | ||
| Q3 25 | $92.4M | $3.9M | ||
| Q2 25 | $101.5M | $68.7K | ||
| Q1 25 | $108.8M | $2.9M | ||
| Q4 24 | $120.4M | $5.6M | ||
| Q3 24 | $118.6M | $4.3M | ||
| Q2 24 | $118.2M | $5.3M | ||
| Q1 24 | $127.3M | — |
| Q4 25 | $42.4M | $79.1K | ||
| Q3 25 | $42.4M | $84.6K | ||
| Q2 25 | $42.4M | $642.8K | ||
| Q1 25 | $42.4M | $715.4K | ||
| Q4 24 | $40.0M | $787.7K | ||
| Q3 24 | $37.1M | $858.6K | ||
| Q2 24 | $35.0M | $1.6M | ||
| Q1 24 | $35.0M | $748.8K |
| Q4 25 | $63.9M | $5.3M | ||
| Q3 25 | $64.3M | $-1.7M | ||
| Q2 25 | $70.0M | $-59.4M | ||
| Q1 25 | $77.6M | $-23.1M | ||
| Q4 24 | $87.5M | $-88.9M | ||
| Q3 24 | $95.0M | $-39.3M | ||
| Q2 24 | $101.6M | $-53.0M | ||
| Q1 24 | $109.2M | $-173.0M |
| Q4 25 | $115.3M | $56.9M | ||
| Q3 25 | $116.3M | $58.5M | ||
| Q2 25 | $122.0M | $46.2M | ||
| Q1 25 | $129.7M | $47.4M | ||
| Q4 24 | $142.8M | $61.0M | ||
| Q3 24 | $143.6M | $47.1M | ||
| Q2 24 | $149.7M | $49.1M | ||
| Q1 24 | $155.6M | $50.1M |
| Q4 25 | 0.66× | 0.01× | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | 0.46× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.32× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.8M | $2.4M |
| Free Cash FlowOCF − Capex | $-2.0M | $2.3M |
| FCF MarginFCF / Revenue | -9.7% | 12.2% |
| Capex IntensityCapex / Revenue | 0.8% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.8M | $2.4M | ||
| Q3 25 | $-8.7M | $-6.6M | ||
| Q2 25 | $-7.5M | $-2.3M | ||
| Q1 25 | $-11.6M | $-2.3M | ||
| Q4 24 | $-3.5M | $3.5M | ||
| Q3 24 | $362.0K | $162.2K | ||
| Q2 24 | $-9.5M | $-2.2M | ||
| Q1 24 | $-9.8M | $-10.2M |
| Q4 25 | $-2.0M | $2.3M | ||
| Q3 25 | $-8.9M | $-6.8M | ||
| Q2 25 | $-7.8M | $-2.7M | ||
| Q1 25 | — | $-2.6M | ||
| Q4 24 | $-3.6M | $3.4M | ||
| Q3 24 | $311.0K | $116.5K | ||
| Q2 24 | $-9.5M | $-2.3M | ||
| Q1 24 | $-9.9M | $-10.4M |
| Q4 25 | -9.7% | 12.2% | ||
| Q3 25 | -44.7% | -28.6% | ||
| Q2 25 | -39.6% | -15.0% | ||
| Q1 25 | — | -30.0% | ||
| Q4 24 | -18.9% | 18.2% | ||
| Q3 24 | 1.5% | 0.6% | ||
| Q2 24 | -44.7% | -15.6% | ||
| Q1 24 | -51.4% | -51.5% |
| Q4 25 | 0.8% | 0.9% | ||
| Q3 25 | 0.9% | 1.0% | ||
| Q2 25 | 1.1% | 2.4% | ||
| Q1 25 | 0.0% | 4.2% | ||
| Q4 24 | 0.7% | 0.5% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 0.4% | 0.7% | ||
| Q1 24 | 0.6% | 1.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
ZEO
| Nonrelated Party | $18.1M | 98% |
| Related Party | $432.1K | 2% |
